SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chiron

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Keith Fauci who wrote (15)5/20/1996 9:24:00 PM
From: Tara Cobble   of 23
 
Chiron Fans - You may want to look at Genome Therapeutics Corp. thread.

Also in response #4 has some information that is repeated below:

Look in Wednesday 5/15/96 USA Today "Money" section page 3B
Street Talk Section:
titled Short This:

The article has some comments from Money Manager Stephen Flaks, who runs the
Private Investment Fund - Flaks Fund. It was up more than 200% last year.
He was very high on Chiron last year and did extremely well. A quote from
the article "He still likes Biotech and his new favorite is Genome
Therapeutics which recently sank 30% to under $10 a share."

The article also mentions 2 retail stocks that he does not find favorable and that
he is short selling.

If there are any comments or input to Genome Therapeutics Corp. thread, I would
appreaciate your comments.

Thanks and Good Luck, Tara
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext